Kyprolis® (carfilzomib) in combination with either lenalidomide and dexamethasone or dexamethasone alone is indicated for the treatment of adult patients with multiple myeloma who have received at least one prior therapy.

*Significant improvement in median progression-free survival with both KRd and Kd combination treatments.1,2


  • 58th ASH Annual Meeting & Exposition

    December 3-6, 2016

    San Diego, CA

Please read the SmPC for full comprehensive safety information


  1. Stewart AK et al. N Engl J Med 2015;372:142–152.
  2. Dimopoulos MA et al. Lancet Oncol 2016;17:27–38.

Terms of Use

The information contained in this site is for European healthcare professionals only.